NVST
Envista Holdings CorpHealthcare · $4.3B market cap
Verdict
We can't put a fair value on NVST right now. It lost money in at least 2 of its last 3 years, so one year of cash flow isn't a reliable base to value it on.
Business quality
0 of 5 clear the 10% bar. What are the Big Five?
Follow NVST
Track it on your watchlist and see the full analysis. Free.
Create a free accountSuperinvestors
6 of the investors we track hold NVST. In Q2 2026, 1 added, 3 trimmed and 1 sold out. Who we track
John Rogers
Ariel Investments · as of Q2 2026
$258.7M
9,818,177 shares
Bill Nygren
Oakmark Funds · as of Q2 2026
$72.6M
2,756,781 shares
Tweedy Browne
Tweedy Browne · as of Q2 2026
$37.8M
1,435,248 shares
Richard Pzena
Pzena Investment Management · as of Q2 2026
$30.5M
1,157,273 shares
Howard Marks
Oaktree Capital Management · as of Q2 2026
$10.3M
10,206,000 shares
Show all 6 holdersShow fewer
First Eagle Investment Management
First Eagle Investment Management · as of Q2 2026
$9.8M
372,500 shares
Moves in Q2 2026
Added: First Eagle Investment Management
Trimmed: Bill Nygren, Richard Pzena, Howard Marks
Sold out: First Pacific Advisors
About Envista Holdings Corp
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and…
Medical - Instruments & Supplies
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works